
Scarlett Y. Goon
Supervisory Patent Examiner (ID: 11557, Phone: (571)270-5241 , Office: P/1600 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1693, 1600, 1623, 4131 |
| Total Applications | 525 |
| Issued Applications | 185 |
| Pending Applications | 17 |
| Abandoned Applications | 329 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6080392
[patent_doc_number] => 20110142971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'USE OF AN ONION EXTRACT FOR MAKING A COMPOSITION TO CONTROL WEIGHT GAIN'
[patent_app_type] => utility
[patent_app_number] => 13/034847
[patent_app_country] => US
[patent_app_date] => 2011-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7568
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142971.pdf
[firstpage_image] =>[orig_patent_app_number] => 13034847
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/034847 | USE OF AN ONION EXTRACT FOR MAKING A COMPOSITION TO CONTROL WEIGHT GAIN | Feb 24, 2011 | Abandoned |
Array
(
[id] => 6084825
[patent_doc_number] => 20110144316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'METHOD FOR RESTRUCTURING THE EPIDERMIS USING A POLYOL-GLYCOSIDE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/031681
[patent_app_country] => US
[patent_app_date] => 2011-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6357
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144316.pdf
[firstpage_image] =>[orig_patent_app_number] => 13031681
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/031681 | Method for restructuring the epidermis using a polyol-glycoside composition | Feb 21, 2011 | Issued |
Array
(
[id] => 7560946
[patent_doc_number] => 20110274778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases'
[patent_app_type] => utility
[patent_app_number] => 12/929684
[patent_app_country] => US
[patent_app_date] => 2011-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11047
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20110274778.pdf
[firstpage_image] =>[orig_patent_app_number] => 12929684
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/929684 | Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases | Feb 7, 2011 | Issued |
Array
(
[id] => 6186336
[patent_doc_number] => 20110124596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'COMPOSITION FOR TREATING INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/019761
[patent_app_country] => US
[patent_app_date] => 2011-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2810
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20110124596.pdf
[firstpage_image] =>[orig_patent_app_number] => 13019761
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/019761 | COMPOSITION FOR TREATING INFLAMMATORY DISEASES | Feb 1, 2011 | Abandoned |
Array
(
[id] => 6187028
[patent_doc_number] => 20110124850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'Glycorandomization and Production of Novel Vancomycin Analogs'
[patent_app_type] => utility
[patent_app_number] => 13/018811
[patent_app_country] => US
[patent_app_date] => 2011-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 36192
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20110124850.pdf
[firstpage_image] =>[orig_patent_app_number] => 13018811
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/018811 | Glycorandomization and production of novel erythromycin analogs | Jan 31, 2011 | Issued |
Array
(
[id] => 9937410
[patent_doc_number] => 08987216
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-24
[patent_title] => 'Polysulfated glycosides and salts thereof'
[patent_app_type] => utility
[patent_app_number] => 13/013153
[patent_app_country] => US
[patent_app_date] => 2011-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16718
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13013153
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/013153 | Polysulfated glycosides and salts thereof | Jan 24, 2011 | Issued |
Array
(
[id] => 8649577
[patent_doc_number] => 20130035307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-07
[patent_title] => 'METHODS FOR TREATING OR PREVENTING THE SPREAD OF CANCER USING SEMI-SYNTHETIC GLYCOSAMINOGLYCOSAN ETHERS'
[patent_app_type] => utility
[patent_app_number] => 13/575069
[patent_app_country] => US
[patent_app_date] => 2011-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15261
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575069
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/575069 | METHODS FOR TREATING OR PREVENTING THE SPREAD OF CANCER USING SEMI-SYNTHETIC GLYCOSAMINOGLYCOSAN ETHERS | Jan 23, 2011 | Abandoned |
Array
(
[id] => 8768038
[patent_doc_number] => 20130096075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF METABOLIC SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 13/261527
[patent_app_country] => US
[patent_app_date] => 2011-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6025
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261527
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/261527 | COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF METABOLIC SYNDROME | Jan 13, 2011 | Abandoned |
Array
(
[id] => 10089145
[patent_doc_number] => 09125953
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'Halogenated ether complex'
[patent_app_type] => utility
[patent_app_number] => 13/522109
[patent_app_country] => US
[patent_app_date] => 2011-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1993
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13522109
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/522109 | Halogenated ether complex | Jan 13, 2011 | Issued |
Array
(
[id] => 6038354
[patent_doc_number] => 20110091403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE'
[patent_app_type] => utility
[patent_app_number] => 12/977317
[patent_app_country] => US
[patent_app_date] => 2010-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12976
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20110091403.pdf
[firstpage_image] =>[orig_patent_app_number] => 12977317
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/977317 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE | Dec 22, 2010 | Abandoned |
Array
(
[id] => 6120022
[patent_doc_number] => 20110083991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'HYALURONIC ACID DERIVATIVE AND DRUG CONTAINING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/971361
[patent_app_country] => US
[patent_app_date] => 2010-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 29471
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20110083991.pdf
[firstpage_image] =>[orig_patent_app_number] => 12971361
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/971361 | HYALURONIC ACID DERIVATIVE AND DRUG CONTAINING THE SAME | Dec 16, 2010 | Abandoned |
Array
(
[id] => 6064902
[patent_doc_number] => 20110201794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'Disaccharides for drug discovery'
[patent_app_type] => utility
[patent_app_number] => 12/926913
[patent_app_country] => US
[patent_app_date] => 2010-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16101
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201794.pdf
[firstpage_image] =>[orig_patent_app_number] => 12926913
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/926913 | Disaccharides for drug discovery | Dec 16, 2010 | Abandoned |
Array
(
[id] => 6122016
[patent_doc_number] => 20110077391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'HYDROXYALKYL METHYLCELLULOSE HAVING SOLUBILITY AND THERMOREVERSIBLE GELATION PROPERTIES IMPROVED'
[patent_app_type] => utility
[patent_app_number] => 12/961006
[patent_app_country] => US
[patent_app_date] => 2010-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5074
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20110077391.pdf
[firstpage_image] =>[orig_patent_app_number] => 12961006
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/961006 | Hydroxyalkyl methylcellulose having solubility and thermoreversible gelation properties improved | Dec 5, 2010 | Issued |
Array
(
[id] => 6084846
[patent_doc_number] => 20110144322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'Hydroxypropylmethylcellulose Having High Thermal Gel Strength, Method For Producing The Same And Food Comprising The Hydroxypropylmethylcellulose'
[patent_app_type] => utility
[patent_app_number] => 12/959659
[patent_app_country] => US
[patent_app_date] => 2010-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7371
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144322.pdf
[firstpage_image] =>[orig_patent_app_number] => 12959659
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/959659 | Hydroxypropylmethylcellulose Having High Thermal Gel Strength, Method For Producing The Same And Food Comprising The Hydroxypropylmethylcellulose | Dec 2, 2010 | Abandoned |
Array
(
[id] => 8496454
[patent_doc_number] => 20120295863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'Dual-Action Compounds Targeting Adenosine A2A Receptor and Adenosine Transporter for Prevention and Treatment of Neurodegenerative Diseases'
[patent_app_type] => utility
[patent_app_number] => 13/508797
[patent_app_country] => US
[patent_app_date] => 2010-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16692
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508797
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/508797 | Dual-Action Compounds Targeting Adenosine A2A Receptor and Adenosine Transporter for Prevention and Treatment of Neurodegenerative Diseases | Nov 11, 2010 | Abandoned |
Array
(
[id] => 10057288
[patent_doc_number] => 09096633
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Stable needle-shaped crystals of natamycin'
[patent_app_type] => utility
[patent_app_number] => 12/926283
[patent_app_country] => US
[patent_app_date] => 2010-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3702
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12926283
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/926283 | Stable needle-shaped crystals of natamycin | Nov 7, 2010 | Issued |
Array
(
[id] => 6184301
[patent_doc_number] => 20110123692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'CRYSTALLIZATION OF POLYOL COMPOSITIONS, CRYSTALLINE POLYOL COMPOSITION PRODUCT AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/914317
[patent_app_country] => US
[patent_app_date] => 2010-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9844
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20110123692.pdf
[firstpage_image] =>[orig_patent_app_number] => 12914317
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/914317 | Crystallization of polyol compositions, crystalline polyol composition product and use thereof | Oct 27, 2010 | Issued |
Array
(
[id] => 8347904
[patent_doc_number] => 20120208827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'BENZIMIDAZOLES AS FATTY ACID SYNTHASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/504547
[patent_app_country] => US
[patent_app_date] => 2010-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47441
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504547
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/504547 | BENZIMIDAZOLES AS FATTY ACID SYNTHASE INHIBITORS | Oct 26, 2010 | Abandoned |
Array
(
[id] => 6195635
[patent_doc_number] => 20110027390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'Methods for Reducing Cisplatin Nephrotoxicity'
[patent_app_type] => utility
[patent_app_number] => 12/903934
[patent_app_country] => US
[patent_app_date] => 2010-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11276
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20110027390.pdf
[firstpage_image] =>[orig_patent_app_number] => 12903934
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/903934 | Methods for Reducing Cisplatin Nephrotoxicity | Oct 12, 2010 | Abandoned |
Array
(
[id] => 6196655
[patent_doc_number] => 20110028413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'Methods of Reducing Methotrexate Nephrotoxicity'
[patent_app_type] => utility
[patent_app_number] => 12/903950
[patent_app_country] => US
[patent_app_date] => 2010-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11277
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028413.pdf
[firstpage_image] =>[orig_patent_app_number] => 12903950
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/903950 | Methods of Reducing Methotrexate Nephrotoxicity | Oct 12, 2010 | Abandoned |